Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
≥ 26 27 26 27 O
1,500 28 33 28 33 B-lower_bound
/ 33 34 33 34 I-lower_bound
mcL 34 37 34 37 I-lower_bound

Age 0 3 38 41 B-age
18 4 6 42 44 B-lower_bound
years 7 12 45 50 I-lower_bound
or 13 15 51 53 O
older 16 21 54 59 O

Aspartate 0 9 60 69 B-clinical_variable
aminotransferase 10 26 70 86 I-clinical_variable
( 27 28 87 88 I-clinical_variable
AST)/Alanine 28 40 88 100 I-clinical_variable
aminotransferase 41 57 101 117 I-clinical_variable
( 58 59 118 119 I-clinical_variable
ALT 59 62 119 122 I-clinical_variable
) 62 63 122 123 I-clinical_variable
≤ 64 65 124 125 O
2.5 66 69 126 129 B-upper_bound
X 70 71 130 131 I-upper_bound
institutional 72 85 132 145 I-upper_bound
upper 86 91 146 151 I-upper_bound
limit 92 97 152 157 I-upper_bound
of 98 100 158 160 I-upper_bound
normal 101 107 161 167 I-upper_bound

Creatinine 0 10 168 178 B-clinical_variable
within 11 17 179 185 O
normal 18 24 186 192 O
institutional 25 38 193 206 O
limits 39 45 207 213 O
or 46 48 214 216 O
creatinine 49 59 217 227 B-clinical_variable
clearance 60 69 228 237 I-clinical_variable
≥ 70 71 238 239 O
60 72 74 240 242 B-lower_bound
mL 75 77 243 245 I-lower_bound
/ 77 78 245 246 I-lower_bound
min/1.73 78 86 246 254 I-lower_bound
m2 87 89 255 257 I-lower_bound
for 90 93 258 261 O
subjects 94 102 262 270 O
with 103 107 271 275 O
creatinine 108 118 276 286 B-clinical_variable
levels 119 125 287 293 I-clinical_variable
about 126 131 294 299 O
institutional 132 145 300 313 O
normal 146 152 314 320 O

Cryoablation 0 12 321 333 B-treatment
can 13 16 334 337 O
be 17 19 338 340 O
performed 20 29 341 350 O
near 30 34 351 355 O
vessels 35 42 356 363 O
of 43 45 364 366 O
the 46 49 367 370 O
head 50 54 371 375 O
and 55 58 376 379 O
neck 59 63 380 384 O
, 63 64 384 385 O
and 65 68 386 389 O
if 69 71 390 392 O
deemed 72 78 393 399 O
necessary 79 88 400 409 O
tumor 89 94 410 415 B-cancer
may 95 98 416 419 O
be 99 101 420 422 O
displaced 102 111 423 432 O
using 112 117 433 438 O
a 118 119 439 440 O
saline 120 126 441 447 B-treatment
injection 127 136 448 457 I-treatment
( 137 138 458 459 I-treatment
hydro 138 143 459 464 I-treatment
- 143 144 464 465 I-treatment
displacement 144 156 465 477 I-treatment
) 156 157 477 478 I-treatment

Eastern 0 7 479 486 B-clinical_variable
Cooperative 8 19 487 498 I-clinical_variable
Oncology 20 28 499 507 I-clinical_variable
Group 29 34 508 513 I-clinical_variable
( 35 36 514 515 I-clinical_variable
ECOG 36 40 515 519 I-clinical_variable
) 40 41 519 520 I-clinical_variable
performance 42 53 521 532 I-clinical_variable
status 54 60 533 539 I-clinical_variable
≤ 61 62 540 541 O
2 63 64 542 543 B-upper_bound

History 0 7 544 551 O
of 8 10 552 554 O
allergic 11 19 555 563 O
reactions 20 29 564 573 O
attributed 30 40 574 584 O
to 41 43 585 587 O
compounds 44 53 588 597 O
of 54 56 598 600 O
similar 57 64 601 608 O
chemical 65 73 609 617 O
or 74 76 618 620 O
biologic 77 85 621 629 O
composition 86 97 630 641 O
to 98 100 642 644 O
gadolinium 101 111 645 655 B-allergy_name
contrast 112 120 656 664 I-allergy_name
agents 121 127 665 671 I-allergy_name
, 127 128 671 672 O
if 129 131 673 675 O
contrast 132 140 676 684 O
use 141 144 685 688 O
is 145 147 689 691 O
anticipated 148 159 692 703 O
during 160 166 704 710 O
the 167 170 711 714 O
procedure 171 180 715 724 O

Leukocytes 0 10 725 735 B-clinical_variable
≥ 11 12 736 737 O
3,000 13 18 738 743 B-lower_bound
/ 18 19 743 744 I-lower_bound
microliter 19 29 744 754 I-lower_bound
( 30 31 755 756 I-lower_bound
mcL 31 34 756 759 I-lower_bound
) 34 35 759 760 I-lower_bound

Life 0 4 761 765 B-clinical_variable
expectancy 5 15 766 776 I-clinical_variable
of 16 18 777 779 O
greater 19 26 780 787 O
than 27 31 788 792 O
8 32 33 793 794 B-lower_bound
weeks 34 39 795 800 I-lower_bound
in 40 42 801 803 O
the 43 46 804 807 O
opinion 47 54 808 815 O
of 55 57 816 818 O
the 58 61 819 822 O
referring 62 71 823 832 O
clinician 72 81 833 842 O

Participants 0 12 843 855 O
with 13 17 856 860 O
malignant 18 27 861 870 B-cancer
locally 28 35 871 878 O
recurrent 36 45 879 888 O
and/or 46 52 889 895 O
metastatic 53 63 896 906 B-cancer
tumors 64 70 907 913 I-cancer

Participants 0 12 914 926 O
with 13 17 927 931 O
tumors 18 24 932 938 B-cancer
involving 25 34 939 948 O
the 35 38 949 952 O
optic 39 44 953 958 O
chiasm 45 51 959 965 O
, 51 52 965 966 O
brain 53 58 967 972 O
, 58 59 972 973 O
or 60 62 974 976 O
spinal 63 69 977 983 O
cord 70 74 984 988 O

Platelets 0 9 989 998 B-clinical_variable
≥ 10 11 999 1000 O
100,000 12 19 1001 1008 B-lower_bound
/ 19 20 1008 1009 I-lower_bound
microliter 20 30 1009 1019 I-lower_bound
( 31 32 1020 1021 I-lower_bound
mcL 32 35 1021 1024 I-lower_bound
) 35 36 1024 1025 I-lower_bound

Pregnant 0 8 1026 1034 B-pregnancy
women 9 14 1035 1040 B-gender

Since 0 5 1041 1046 O
positron 6 14 1047 1055 B-treatment
emission 15 23 1056 1064 I-treatment
tomography 24 34 1065 1075 I-treatment
- 34 35 1075 1076 I-treatment
computed 35 43 1076 1084 I-treatment
tomography 44 54 1085 1095 I-treatment
( 55 56 1096 1097 I-treatment
PET 56 59 1097 1100 I-treatment
- 59 60 1100 1101 I-treatment
CT 60 62 1101 1103 I-treatment
) 62 63 1103 1104 I-treatment
guidance 64 72 1105 1113 O
requires 73 81 1114 1122 O
the 82 85 1123 1126 O
nuclear 86 93 1127 1134 O
medicine 94 102 1135 1143 O
department 103 113 1144 1154 O
to 114 116 1155 1157 O
administer 117 127 1158 1168 O
a 128 129 1169 1170 O
radionuclide 130 142 1171 1183 O
material 143 151 1184 1192 O
, 151 152 1192 1193 O
the 153 156 1194 1197 O
default 157 164 1198 1205 O
will 165 169 1206 1210 O
be 170 172 1211 1213 O
to 173 175 1214 1216 O
try 176 179 1217 1220 O
to 180 182 1221 1223 O
use 183 186 1224 1227 O
MRI 187 190 1228 1231 B-treatment
guidance 191 199 1232 1240 O

Total 0 5 1241 1246 B-clinical_variable
bilirubin 6 15 1247 1256 I-clinical_variable
within 16 22 1257 1263 O
normal 23 29 1264 1270 O
institutional 30 43 1271 1284 O
limits 44 50 1285 1291 O

Tumor 0 5 1292 1297 B-cancer
displacement 6 18 1298 1310 O
from 19 23 1311 1315 O
nerves 24 30 1316 1322 O
may 31 34 1323 1326 O
be 35 37 1327 1329 O
required 38 46 1330 1338 O
and 47 50 1339 1342 O
will 51 55 1343 1347 O
be 56 58 1348 1350 O
performed 59 68 1351 1360 O
as 69 71 1361 1363 O
deemed 72 78 1364 1370 O
appropriate 79 90 1371 1382 O
to 91 93 1383 1385 O
avoid 94 99 1386 1391 O
nerve 100 105 1392 1397 O
injury 106 112 1398 1404 O

Tumors 0 6 1405 1411 B-cancer
that 7 11 1412 1416 O
are 12 15 1417 1420 O
not 16 19 1421 1424 O
clearly 20 27 1425 1432 O
seen 28 32 1433 1437 O
by 33 35 1438 1440 O
MRI 36 39 1441 1444 B-treatment
but 40 43 1445 1448 O
showing 44 51 1449 1456 O
on 52 54 1457 1459 O
PET 55 58 1460 1463 B-treatment
/ 58 59 1463 1464 O
CT 59 61 1464 1466 B-treatment
will 62 66 1467 1471 O
be 67 69 1472 1474 O
ablated 70 77 1475 1482 O
with 78 82 1483 1487 O
PET 83 86 1488 1491 O
/ 86 87 1491 1492 O
CT 87 89 1492 1494 O
guidance 90 98 1495 1503 O

Uncontrolled 0 12 1504 1516 O
intercurrent 13 25 1517 1529 B-chronic_disease
illness 26 33 1530 1537 I-chronic_disease
including 34 43 1538 1547 O
, 43 44 1547 1548 O
but 45 48 1549 1552 O
not 49 52 1553 1556 O
limited 53 60 1557 1564 O
to 61 63 1565 1567 O
ongoing 64 71 1568 1575 O
or 72 74 1576 1578 O
active 75 81 1579 1585 B-chronic_disease
infection 82 91 1586 1595 I-chronic_disease
, 91 92 1595 1596 O
symptomatic 93 104 1597 1608 O
congestive 105 115 1609 1619 B-chronic_disease
heart 116 121 1620 1625 I-chronic_disease
failure 122 129 1626 1633 I-chronic_disease
, 129 130 1633 1634 O
unstable 131 139 1635 1643 B-chronic_disease
angina 140 146 1644 1650 I-chronic_disease
pectoris 147 155 1651 1659 I-chronic_disease
, 155 156 1659 1660 O
cardiac 157 164 1661 1668 B-chronic_disease
arrhythmia 165 175 1669 1679 I-chronic_disease
, 175 176 1679 1680 O
or 177 179 1681 1683 O
psychiatric 180 191 1684 1695 B-chronic_disease
illness 192 199 1696 1703 I-chronic_disease
/ 199 200 1703 1704 O
social 200 206 1704 1710 B-chronic_disease
situations 207 217 1711 1721 I-chronic_disease
that 218 222 1722 1726 O
would 223 228 1727 1732 O
limit 229 234 1733 1738 O
compliance 235 245 1739 1749 O
with 246 250 1750 1754 O
study 251 256 1755 1760 O
requirements 257 269 1761 1773 O

impaired 0 8 1774 1782 B-chronic_disease
renal 9 14 1783 1788 I-chronic_disease
function 15 23 1789 1797 I-chronic_disease
( 24 25 1798 1799 O
eGFR 25 29 1799 1803 B-clinical_variable
< 30 31 1804 1805 O
60ml 32 36 1806 1810 B-upper_bound
/ 36 37 1810 1811 I-upper_bound
min 37 40 1811 1814 I-upper_bound
) 40 41 1814 1815 O

known 0 5 1816 1821 O
ischemic 6 14 1822 1830 B-chronic_disease
disease 15 22 1831 1838 I-chronic_disease

may 0 3 1839 1842 O
not 4 7 1843 1846 O
be 8 10 1847 1849 O
receiving 11 20 1850 1859 O
any 21 24 1860 1863 O
other 25 30 1864 1869 O
study 31 36 1870 1875 B-treatment
agents 37 43 1876 1882 I-treatment

men 0 3 1883 1886 B-gender

must 0 4 1887 1891 O
agree 5 10 1892 1897 B-contraception_consent
to 11 13 1898 1900 I-contraception_consent
use 14 17 1901 1904 I-contraception_consent
adequate 18 26 1905 1913 I-contraception_consent
contraception 27 40 1914 1927 I-contraception_consent
( 41 42 1928 1929 O
hormonal 42 50 1929 1937 B-contraception_consent
or 51 53 1938 1940 I-contraception_consent
barrier 54 61 1941 1948 I-contraception_consent
method 62 68 1949 1955 I-contraception_consent
of 69 71 1956 1958 I-contraception_consent
birth 72 77 1959 1964 I-contraception_consent
control 78 85 1965 1972 I-contraception_consent
; 85 86 1972 1973 O
abstinence 87 97 1974 1984 B-contraception_consent
) 97 98 1984 1985 O
prior 99 104 1986 1991 O
to 105 107 1992 1994 O
study 108 113 1995 2000 O
entry 114 119 2001 2006 O
and 120 123 2007 2010 O
for 124 127 2011 2014 O
the 128 131 2015 2018 O
duration 132 140 2019 2027 O
of 141 143 2028 2030 O
study 144 149 2031 2036 O
participation 150 163 2037 2050 O

must 0 4 2051 2055 O
have 5 9 2056 2060 O
a 10 11 2061 2062 O
mass 12 16 2063 2067 O
that 17 21 2068 2072 O
is 22 24 2073 2075 O
well 25 29 2076 2080 O
visualized 30 40 2081 2091 O
under 41 46 2092 2097 O
PET 47 50 2098 2101 B-treatment
/ 50 51 2101 2102 O
CT 51 53 2102 2104 B-treatment

must 0 4 2105 2109 O
have 5 9 2110 2114 O
a 10 11 2115 2116 O
mass 12 16 2117 2121 O
that 17 21 2122 2126 O
is 22 24 2127 2129 O
well 25 29 2130 2134 O
- 29 30 2134 2135 O
visualized 30 40 2135 2145 O
under 41 46 2146 2151 O
MRI 47 50 2152 2155 B-treatment

must 0 4 2156 2160 O
have 5 9 2161 2165 O
an 10 12 2166 2168 O
advanced 13 21 2169 2177 O
head 22 26 2178 2182 B-cancer
, 26 27 2182 2183 O
neck 28 32 2184 2188 B-cancer
or 33 35 2189 2191 O
spine 36 41 2192 2197 B-cancer
malignant 42 51 2198 2207 I-cancer
tumor 52 57 2208 2213 I-cancer
that 58 62 2214 2218 O
would 63 68 2219 2224 O
potentially 69 80 2225 2236 O
benefit 81 88 2237 2244 O
from 89 93 2245 2249 O
a 94 95 2250 2251 O
minimally 96 105 2252 2261 O
invasive 106 114 2262 2270 O
procedure 115 124 2271 2280 O

must 0 4 2281 2285 O
have 5 9 2286 2290 O
histologically 10 24 2291 2305 O
confirmed 25 34 2306 2315 O
malignant 35 44 2316 2325 B-cancer
tumor 45 50 2326 2331 I-cancer
that 51 55 2332 2336 O
is 56 58 2337 2339 O
metastatic 59 69 2340 2350 B-cancer
or 70 72 2351 2353 O
unresectable 73 85 2354 2366 O
and 86 89 2367 2370 O
for 90 93 2371 2374 O
which 94 99 2375 2380 O
standard 100 108 2381 2389 O
curative 109 117 2390 2398 O
or 118 120 2399 2401 O
palliative 121 131 2402 2412 O
measures 132 140 2413 2421 O
do 141 143 2422 2424 O
not 144 147 2425 2428 O
exist 148 153 2429 2434 O
or 154 156 2435 2437 O
are 157 160 2438 2441 O
no 161 163 2442 2444 O
longer 164 170 2445 2451 O
effective 171 180 2452 2461 O

must 0 4 2462 2466 O
have 5 9 2467 2471 O
sustained 10 19 2472 2481 O
all 20 23 2482 2485 O
available 24 33 2486 2495 O
treatment 34 43 2496 2505 B-treatment
options 44 51 2506 2513 O
( 52 53 2514 2515 O
radiation 53 62 2515 2524 B-treatment
, 62 63 2524 2525 O
chemotherapy 64 76 2526 2538 B-treatment
, 76 77 2538 2539 O
surgery 78 85 2540 2547 B-treatment
) 85 86 2547 2548 O
as 87 89 2549 2551 O
verified 90 98 2552 2560 O
by 99 101 2561 2563 O
the 102 105 2564 2567 O
Dana 106 110 2568 2572 O
Farber 111 117 2573 2579 O
Cancer 118 124 2580 2586 O
Institute 125 134 2587 2596 O
's 134 136 2596 2598 O
Head 137 141 2599 2603 O
and 142 145 2604 2607 O
Neck 146 150 2608 2612 O
Tumor 151 156 2613 2618 O
Board 157 162 2619 2624 O

tumors 0 6 2625 2631 B-cancer
that 7 11 2632 2636 O
encase 12 18 2637 2643 O
any 19 22 2644 2647 O
major 23 28 2648 2653 O
blood 29 34 2654 2659 O
vessel 35 41 2660 2666 O
( 42 43 2667 2668 O
carotid 43 50 2668 2675 O
, 50 51 2675 2676 O
jugular 52 59 2677 2684 O
, 59 60 2684 2685 O
vertebral 61 70 2686 2695 O
) 70 71 2695 2696 O

who 0 3 2697 2700 O
have 4 8 2701 2705 O
had 9 12 2706 2709 O
chemotherapy 13 25 2710 2722 B-treatment
or 26 28 2723 2725 O
radiotherapy 29 41 2726 2738 B-treatment
within 42 48 2739 2745 O
4 49 50 2746 2747 O
weeks 51 56 2748 2753 O
( 57 58 2754 2755 O
6 58 59 2755 2756 B-upper_bound
weeks 60 65 2757 2762 I-upper_bound
for 66 69 2763 2766 O
nitrosoureas 70 82 2767 2779 B-treatment
or 83 85 2780 2782 O
mitomycin 86 95 2783 2792 B-treatment
C 96 97 2793 2794 I-treatment
) 97 98 2794 2795 O
prior 99 104 2796 2801 O
to 105 107 2802 2804 O
entering 108 116 2805 2813 O
the 117 120 2814 2817 O
study 121 126 2818 2823 O
or 127 129 2824 2826 O
those 130 135 2827 2832 O
who 136 139 2833 2836 O
have 140 144 2837 2841 O
not 145 148 2842 2845 O
recovered 149 158 2846 2855 O
from 159 163 2856 2860 O
adverse 164 171 2861 2868 O
events 172 178 2869 2875 O
due 179 182 2876 2879 O
to 183 185 2880 2882 O
agents 186 192 2883 2889 O
administered 193 205 2890 2902 O
more 206 210 2903 2907 O
than 211 215 2908 2912 O
4 216 217 2913 2914 O
weeks 218 223 2915 2920 O
earlier 224 231 2921 2928 O

with 0 4 2929 2933 O
a 5 6 2934 2935 O
blood 7 12 2936 2941 B-clinical_variable
glucose 13 20 2942 2949 I-clinical_variable
level 21 26 2950 2955 I-clinical_variable
of 27 29 2956 2958 O
> 30 31 2959 2960 O
200mg 32 37 2961 2966 B-lower_bound
/ 37 38 2966 2967 I-lower_bound
dl 38 40 2967 2969 I-lower_bound
prior 41 46 2970 2975 I-lower_bound
to 47 49 2976 2978 O
the 50 53 2979 2982 O
baseline 54 62 2983 2991 O
study 63 68 2992 2997 O

with 0 4 2998 3002 O
known 5 10 3003 3008 O
brain 11 16 3009 3014 B-cancer
metastases 17 27 3015 3025 I-cancer
should 28 34 3026 3032 O
be 35 37 3033 3035 O
excluded 38 46 3036 3044 O
from 47 51 3045 3049 O
this 52 56 3050 3054 O
clinical 57 65 3055 3063 O
trial 66 71 3064 3069 O
because 72 79 3070 3077 O
of 80 82 3078 3080 O
their 83 88 3081 3086 O
poor 89 93 3087 3091 O
prognosis 94 103 3092 3101 O
and 104 107 3102 3105 O
because 108 115 3106 3113 O
they 116 120 3114 3118 O
often 121 126 3119 3124 O
develop 127 134 3125 3132 O
progressive 135 146 3133 3144 B-chronic_disease
neurologic 147 157 3145 3155 I-chronic_disease
dysfunction 158 169 3156 3167 I-chronic_disease
that 170 174 3168 3172 O
would 175 180 3173 3178 O
confound 181 189 3179 3187 O
the 190 193 3188 3191 O
evaluation 194 204 3192 3202 O
of 205 207 3203 3205 O
neurologic 208 218 3206 3216 O
and 219 222 3217 3220 O
other 223 228 3221 3226 O
adverse 229 236 3227 3234 O
events 237 243 3235 3241 O

women 0 5 3242 3247 B-gender
of 6 8 3248 3250 O
child 9 14 3251 3256 O
- 14 15 3256 3257 O
bearing 15 22 3257 3264 O
potential 23 32 3265 3274 O

